2 terminated. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Nirmish Shah: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AB1 in Adult Patients With Sickle Cell Disease (SCD) AB1 - Sickle Cell Disease | Phase 1 / Phase 2 | Terminated | Nirmish Shah | 16 | 2022-12-05 | 2026-10-15 |
| Apixaban in Patients With Sickle Cell Disease Apixaban, Placebo - Vaso-occlusive Crisis, Reduction in Hospitalizations | Phase 3 | Terminated | Nirmish Shah | 16 | 2015-01-01 | 2020-03-11 |
Anemia, Sickle Cell (2) · Vaso-Occlusive Crises (1)
apixaban (1)
United States (2)